Overview of Immunohistochemistry (IHC): Global Markets to 2022
Press Release – 03
Jan 2019
Research
and Development News
--
.
.
Latest
Update
"Immunohistochemistry (IHC): Global Markets to 2022"
with Industries Survey | Global Current Growth and Future.
'
'
The author reached out to many industry contacts,
including Chris La Placa, who is a histotechnologist at BIO SB Inc.
Chris has many years of hands-on experience, so it is instructive
that he says Quote: I agree that the value of the IHC industry is
growing and will continue to grow in the coming years. Many
pathologists have previously used more basic tissue stains to
identify entire structures within human tissue, but IHC is an
advantage as it can identify individual proteins. Its application in
diagnosing infectious diseases such as syphilis and tuberculosis is
also growing in popularity. My company distributes primary antibodies
with specificity for bacteria such as H. pylori, T. pallidum, T.
gondii, and P. jirovecii (among many others), and these are some of
our top sellers. Additionally, we manufacture and sell anchorage
dependent cell lines embedded and mounted to a slide that can be
stained by IHC. These can be used as controls for validation of
patient tissues and are of great interest to pathologists around the
world.
'
'
Continuous
technology and methodological improvements adds value to this type of
field especially, where small details and time savings make can make
a big difference. For Peter Rauch an MD at Candor Bioscience GMBH we
asked which immunoassay solution is the most widely adopted
immunoassay in their operating region?
Quote: For us it is the ELISA market, where we sell most of our products, including the wide range of commercial diagnostic ELISA. Understanding regional variations can be an effective way to optimize business approaches in a fast changing landscape.
The global Immunohistochemistry market is projected to rise at a CAGR of REDACTED during the forecast period of 2017 through 2022. In 2022, total revenues are expected to reach more than REDACTED,registering an increment from REDACTED in 2017.. .
Quote: For us it is the ELISA market, where we sell most of our products, including the wide range of commercial diagnostic ELISA. Understanding regional variations can be an effective way to optimize business approaches in a fast changing landscape.
The global Immunohistochemistry market is projected to rise at a CAGR of REDACTED during the forecast period of 2017 through 2022. In 2022, total revenues are expected to reach more than REDACTED,registering an increment from REDACTED in 2017.. .
– For
Other Requirement and Enquiry_
https://www.researchmoz.us/enquiry.php?type=E&repid=1854820
'
'
The report
provides an analysis based on each market segment which includes
products, applications and end users. The product segment is further
sub-segmented into IHC antibodies, reagents, kits and equipment. The
antibodies held the largest market share of REDACTED in 2017 in terms
of revenue followed by reagents, equipment and kits. By 2022, total
revenue from the antibodies segment is expected toreach more than
REDACTED. Whereas, the reagents segment is estimated to rise at the
highest CAGR of REDACTED through 2022. Total revenue from the
reagents segment is expected to reach REDACTED million by
2022."
"Report Scope
The scope of this market report is widely characterized by products that include antibodies, equipment, kits and reagents. The total market revenue is restricted to the revenues obtained from the sales of the products required to perform IHC testing successfully. This report covers the different applications of immunohistochemistry in drugs and diagnostics.
Report Includes
- 56 data tables and 65 additional tables
- An overview of the global markets and expected consumption for immunohistochemistry (IHC) technologies
- Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Coverage of major trends and challenges that affect the market and the supplier landscape
- End-use industry coverage, including hospitals and diagnostic laboratories, and research institutes
- Evaluation of the market's dynamics, including growth drivers and restraints
- Company profiles of major players in the market, including Abbott Laboratories, Abcam, Abnova, Danaher Corp. and PeproTech GmbH"
"Report Scope
The scope of this market report is widely characterized by products that include antibodies, equipment, kits and reagents. The total market revenue is restricted to the revenues obtained from the sales of the products required to perform IHC testing successfully. This report covers the different applications of immunohistochemistry in drugs and diagnostics.
Report Includes
- 56 data tables and 65 additional tables
- An overview of the global markets and expected consumption for immunohistochemistry (IHC) technologies
- Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Coverage of major trends and challenges that affect the market and the supplier landscape
- End-use industry coverage, including hospitals and diagnostic laboratories, and research institutes
- Evaluation of the market's dynamics, including growth drivers and restraints
- Company profiles of major players in the market, including Abbott Laboratories, Abcam, Abnova, Danaher Corp. and PeproTech GmbH"
"Summary
Immunohistochemistry (IHC) is an umbrella term which combines immunological, biochemical and anatomical techniques to image and localize discrete components in tissues with the help of antibodiesantigen interaction. The use of IHC helps in the documentation and visualization of the high-resolution distribution of cellular components and localization of the antigens of the cells within their proper histological context. The unique properties of IHC testing to precisely localize the antigens, identify the cell type and the tumor, has leveraged its wide adoption in diagnosis, drug development and biological research. IHC tests are employed as a confirmatory procedure or a primary tool for the diagnosis of
various diseases including cancer, cardiovascular, infectious and other diseases.
Immunohistochemistry (IHC) is an umbrella term which combines immunological, biochemical and anatomical techniques to image and localize discrete components in tissues with the help of antibodiesantigen interaction. The use of IHC helps in the documentation and visualization of the high-resolution distribution of cellular components and localization of the antigens of the cells within their proper histological context. The unique properties of IHC testing to precisely localize the antigens, identify the cell type and the tumor, has leveraged its wide adoption in diagnosis, drug development and biological research. IHC tests are employed as a confirmatory procedure or a primary tool for the diagnosis of
various diseases including cancer, cardiovascular, infectious and other diseases.
Continue.....
– More
Clear Details get Full Table of Contents_
https://www.researchmoz.us/immunohistochemistry-ihc-global-markets-to-2022-report.html/toc
About
Researchmoz,
ResearchMoz
is the world’s fastest growing collection of market research
reports worldwide. Our database is composed of current market studies
from over 100 featured publishers worldwide. Our market research
databases integrate statistics with analysis from global, regional,
country and company perspectives. ResearchMoz’s service portfolio
also includes value-added services such as market research
customization, competitive landscaping, and in-depth surveys,
delivered by a team of experienced Research
Coordinators.
--Researchmoz Global Pvt. Ltd.--
--Researchmoz Global Pvt. Ltd.--
Mr.
Nachiket G.
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074www.researchmoz.us
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074www.researchmoz.us
Comments
Post a Comment